Ayca Bilginoglu Topcu

Dr. Ayca Bilginoglu Topcu


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2008 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
NYN Yaras
N Yaras
MSM Sariahmetoglu
M Sariahmetoglu
ATAyca Bilginoglu Topcu
Ayca Bilginoglu Topcu
AAA Aydemir‐Koksoy
A Aydemir‐Koksoy
AOA Onay‐Besikci
A Onay‐Besikci
RSRichard Schulz
Richard Schulz

9 November 2010 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
ETErkan Tuncay
Erkan Tuncay
ATAyca Bilginoglu Topcu
Ayca Bilginoglu Topcu
NSNazli N. Sozmen
Nazli N. Sozmen
EZEsma N. Zeydanli
Esma N. Zeydanli
MUMehmet Ugur
Mehmet Ugur
BTBelma Turan
Belma Turan
Zinc exists in biological systems as bound and histochemically reactive free Zn2+. It is an essential structural constituent of many proteins, including enzymes from cellular signalling pathways, in which it functions as a signalling molecule. In cardiomyocytes at rest, Zn2+ concentration is in the nanomolar range. Very little is known about precise mechanisms controlling the intracellular distribution of Zn2+ and its variations during cardiac function. Live-cell detection of intracellular Zn2+ has become feasible through the recent development of Zn2+-sensitive and –selective fluorophores able to distinguish Zn2+ from Ca2+. Here, in freshly isolated rat cardiomyocytes, we investigated the rapid changes in Zn2+ homeostasis using the Zn2+-specific fluorescent dye, FluoZin-3, in comparison to Ca2+-dependent fluo-3 fluorescence. Zn2+ sparks and Zn2+ transients, in quiescent and electrically stimulated cardiomyocytes, respectively, were visualized in a similar manner to known rapid Ca2+ changes. Both Zn2+ sparks and Zn2+ transients required Ca2+ entry. Inhibiting the sarcoplasmic reticulum Ca2+ release or increasing the Ca2+ load in a low-Na+ solution suppressed or increased Zn2+ movements, respectively. Mitochondrial inhibitors slightly reduced both Zn2+ sparks and Zn2+ transients. Oxidation by H2O2 facilitated and acidic pH inhibited the Ca2+-dependent Zn2+ release. It is proposed that Zn2+ release during the cardiac cycle results mostly from intracellular free Ca2+ increase, triggering production of reactive oxygen species that induce changes in metal-binding properties of metallothioneins and other redox-active proteins, aside from ionic exchange on these proteins.

1 February 2007 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
NYNazmi Yaras
Nazmi Yaras
ATAyca Bilginoglu Topcu
Ayca Bilginoglu Topcu
GVGuy Vassort
Guy Vassort
BTBelma Turan
Belma Turan
Stimulation of local renin-angiotensin system and increased levels of oxidants characterize the diabetic heart. Downregulation of ANG II type 1 receptors (AT1) and enhancement in PKC activity in the heart point out the role of AT1blockers in diabetes. The purpose of this study was to evaluate a potential role of an AT1blocker, candesartan, on abnormal Ca2+release mechanisms and its relationship with PKC in the cardiomyocytes from streptozotocin-induced diabetic rats. Cardiomyocytes were isolated enzymatically and then incubated with either candesartan or a nonspecific PKC inhibitor bisindolylmaleimide I (BIM) for 6–8 h at 37°C. Both candesartan and BIM applied on diabetic cardiomyocytes significantly restored the altered kinetic parameters of Ca2+transients, as well as depressed Ca2+loading of sarcoplasmic reticulum, basal Ca2+level, and spatiotemporal properties of the Ca2+sparks. In addition, candesartan and BIM significantly antagonized the hyperphosphorylation of cardiac ryanodine receptor (RyR2) and restored the depleted protein levels of both RyR2 and FK506 binding protein 12.6 (FKBP12.6). Furthermore, candesartan and BIM also reduced the increased PKC levels and oxidized protein thiol level in membrane fraction of diabetic rat cardiomyocytes. Taken together, these data demonstrate that AT1receptor blockade protects cardiomyocytes from development of cellular alterations typically associated with Ca2+release mechanisms in diabetes mellitus. Prevention of these alterations by candesartan may present a useful pharmacological strategy for the treatment of diabetic cardiomyopathy.

1 September 2010 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
AAAslihan Aydemir-Koksoy
Aslihan Aydemir-Koksoy
ATAyca Bilginoglu Topcu
Ayca Bilginoglu Topcu
MSMeltem Sariahmetoglu
Meltem Sariahmetoglu
RSRichard Schulz
Richard Schulz
BTBelma Turan
Belma Turan

1 January 2014 in Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
Verified
Journal Article
Closed access
ATAyca Bilginoglu Topcu
Ayca Bilginoglu Topcu
Adriamycin is one of the most widely used anticancer drugs. The major limiting factor of using this drug is the development of cardiotoxicity. However, melatonin (N-acetyl-5-methoxytryptamine) is a ubiquitous molecule as a good antioxidant that may protect the heart. We investigated whether or not pretreatment with melatonin can attenuate adriamycin-induced cardiotoxicity. All procedures and experiments were approved by the Animal Ethics Committee of Gazi Osman Paşa University (2012-HADYEK-022). Adult male Wistar-Albino rats were randomly divided into four groups, namely control (CON, n=7), melatonin (MEL, n=7), adriamycin (ADR, n=7), and adriamycin+melatonin (ADR+MEL, n=7) groups. Cardiotoxicity in rats was induced by adriamycin injection (cumulative dose: 18 mg/kg, intraperitoneal [i.p.]) at an interval of 24 hours (h) on the 5th, 6th and 7th days. Rats receiving melatonin treatment in the adriamycin group received melatonin (10 mg/kg/day, i.p.) for 7 days and were injected with adriamycin (18 mg/kg, i.p.) on 5th, 6th and 7th days. On the 8th day, gravimetric, electrocardiography (ECG) and biochemical parameters were assessed. Adriamycin induction caused changes in the ECG pattern, including ST-segment elevation and decreased R-amplitude, increase in the serum levels of cardiac injury markers (creatine kinase [CK], CK-MB, aspartate transaminase, and lactate dehydrogenase), decrease in the antioxidant enzymes activity (superoxide dismutase, glutathione peroxidase), elevated lipid peroxidation (malondialdehyde), and altered lipid profile in the serum. Melatonin treatment prevented all the parameters of adriamycin-induced cardiotoxicity in rats. Melatonin has a protective effect on the heart against adriamycin-induced cardiotoxicity in rats.

9 December 2012 in Cardiovascular Toxicology
Verified
Journal Article
Closed access
PDF file
ATAyca Bilginoglu Topcu
Ayca Bilginoglu Topcu
HKHilmi Burak Kandilci
Hilmi Burak Kandilci
BTBelma Turan
Belma Turan